Last reviewed · How we verify
NCT06176105: MATER
Mortality After Transfusion of Ever-pregnant Donor Red Blood Cells
trial in Anemia in 101,000 participants. Completed in 1 October 2020.
1 October 2020
Quick facts
| Lead sponsor | Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 101,000 |
| Start date | 1 October 2019 |
| Primary completion | 1 October 2020 |
| Estimated completion | 1 October 2020 |
| Sites | 1 location across Netherlands |
Conditions studied
- Anemia — all drugs for Anemia →
Sponsor
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
Who can join
Eligibility, any sex, with Anemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The MATER study is an observational cohort study on first ever transfusion recipients in six hospitals in the Netherlands, with information collected on both donor and patient characteristics. We aim to further specify which combination of characteristics of both donors and patients determine the increased risk of mortality after blood transfusions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06176105
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anemia
Currently open trials in the same condition.
- NCT07422480 — A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel · Phase 3 · recruiting
- NCT06968936 — Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy · NA · recruiting
- NCT07328191 — Quality of Life-Guided Transfusion in Refractory MDS or AML · NA · recruiting
- NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
- NCT07400796 — Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia · recruiting
Other Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research trials
Trials by the same sponsor.
- NCT04626661 — Mitochondrial Oxygen Measurement Variability in Critically Ill Patients (INOX Variability Study) · completed
- NCT03842722 — Insufficient Oxygenation in Septic Patients · completed
- NCT03505086 — Bleeding In Thrombocytopenia Explained · recruiting
- NCT03092297 — Insufficient Cellular Oxygen in ICU Patients With Anaemia · terminated
- NCT03110887 — Monitoring Outcome in Neonatal Thrombocytopenia · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06176105 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
- Last refreshed: 19 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06176105.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing